Following years of growth and favourable market trends, the
global life sciences industry now finds itself facing a ‘new normal’. By any
measure it is still a stand-out performer globally, and a key strategic area
for the EMEA region. However, markets are changing.
Life science companies must adopt new business models to
achieve the following:
Making these adjustments successfully will come down to
individual companies’ ability to find, engage and retain the right people. For
the most part, the challenge is about talent and the ability of each
organisation, regardless of location, to source it.
Here, we look at the top five issues facing the industry and
how organisations in the region can respond.
Privacy Statement | Site Map | Code of Conduct | Corporate Social ResponsibilityCopyright